natgillin/translations-raw huggingface dataset:
Invega skal enten tages uden samtidig fødeindtagelse eller sammen med morgenmaden, men patienten må ikke skifte frem og tilbage mellem at tage medicinen sammen med mad den ene dag og uden mad en anden dag.
Invega should be taken either without food or with breakfast, but patients should not switch between taking the medicine with food on one day and without food on another.
Afhængigt af symptomerne kan dosis af Invega justeres til en endelig dosis mellem 3 og 12 mg én gang dagligt.
The dose of Invega can be altered after assessment of symptoms, to a final dose of between 3 and 12 mg once a day.
Det bør anvendes med forsigtighed hos patienter med svær leversygdom.
It should be used with caution in patients who have severe problems with their liver.
Invega anbefales ikke til patienter med svær nyresygdom.
Patients with mild or moderate kidney problems, including some elderly patients, should start with a lower dose of Invega, but it is not recommended for patients with severe kidney problems.
Invega er ikke blevet undersøgt hos patienter under 18 år.
Invega has not been studied in patients under 18 years of age.
Det kaldes et "atypisk" antipsykotisk middel, fordi det adskiller sig fra de ældre antipsykotiske midler, der har været på markedet siden 1950' erne.
It is known as an ‘ atypical’ antipsychotic because it is different from the older antipsychotic medicines that have been available since the 1950s.
Paliperidon er et aktivt nedbrydningsprodukt (en metabolit) af risperidon.
Paliperidone is an active breakdown product (metabolite) of risperidone, another antipsychotic medicine that has been used in the treatment of schizophrenia since the 1990s.
Risperidon er et andet antipsykotisk middel, der var været anvendt til behandling af skizofreni siden 1990' erne.
In the brain, it attaches to several different receptors on the surface of nerve cells.
I hjernen bindes det til flere forskellige typer receptorer på overfladen af nervecellerne.
This disrupts signals transmitted between brain cells by ‘ neurotransmitters’, chemicals that allow nerve cells to communicate with each other.
Derved afbrydes de signaler, som hjernecellerne sender til hinanden ved hjælp af "neurotransmittere", dvs. kemiske stoffer, som nervecellerne kommunikerer med indbyrdes.
Paliperidone acts mainly by blocking the receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin), which are involved in schizophrenia.
Paliperidon virker hovedsagelig ved at blokere receptorerne for neurotransmitterne dopamin og 5- hydroxytryptamin
By blocking these receptors, paliperidone helps to normalise the activity of the brain and reduce symptoms.
Virkningerne af Invega blev først testet i forsøgsmodeller, inden de blev undersøgt hos mennesker.
The effects of Invega were first tested in experimental models before being studied in humans.
Invega var genstand for tre kortvarige hovedundersøgelser med deltagelse af 1 692 voksne med skizofreni.
Invega has been studied in three main short-term studies involving 1,692 adults with schizophrenia.
I alle tre undersøgelser blev Invega i en dosis på mellem 3 og 15 mg sammenlignet med placebo (virkningsløs behandling) og med olanzapin (et andet antipsykotisk lægemiddel).
In all three studies, doses of Invega between 3 and 15 mg a day were compared with placebo (a dummy treatment) and with olanzapine (another antipsychotic medicine).
Virkningen blev hovedsagelig bedømt på ændringen i symptomerne ved anvendelse af en standardskala for skizofreni efter seks uger.
The main measure of effectiveness was the change in the patients ’ symptoms using a standard scale for schizophrenia after six weeks.
Endnu en undersøgelse vedrørte Invegas evne til på lang sigt at forhindre nye symptomer i indtil 35 uger hos 207 patienter, der i forvejen var blevet behandlet for symptomer på skizofreni i en 14 ugers periode.
A further study looked at the long-term effects of Invega in preventing new symptoms for up to 35 weeks in 207 patients who had initially been treated for symptoms of schizophrenia over a 14-week period.
Hvilken fordel viser undersøgelserne, der er ved Invega?
What benefit has Invega shown during the studies?
Invega var mere effektivt end placebo og lige så effektivt som olanzapin til at mindske symptomerne på skizofreni.
Invega was more effective than placebo and as effective as olanzapine in reducing the symptoms of schizophrenia.
I den første kortsigtede undersøgelse medførte placebo et gennemsnitligt faldt i symptomscore på 4, 1 point, sammenlignet med et gennemsnitligt fald på mellem 17, 9 og 23, 3 point hos dem, der fik Invega, og 19, 9 hos dem, der fik olanzapin.
In the first short-term study, patients taking placebo had an average fall in their symptom score of 4.1 points, compared with an average fall of between 17.9 and 23.3 points in those taking Invega and of 19.9 in those taking olanzapine.
De to andre kortsigtede undersøgelser gav tilsvarende resultater.
Similar results were seen in the other two short- term studies.
Invega var også mere effektivt end placebo til at forhindre nye skizofrenisymptomer i langtidsundersøgelsen.
Invega was also more effective than placebo in preventing the occurrence of new symptoms of schizophrenia in the long-term study.
Den hyppigste bivirkning ved brug af Invega (som ses hos flere end 1 ud af 10 patienter) er hovedpine.
The most common side effect with Invega (seen in more than 1 patient in 10) is headache.
Den fuldstændige liste over alle de indberettede bivirkninger for Invega fremgår af indlægssedlen.
For the full list of all side effects reported with Invega, see the Package Leaflet.
Invega bør ikke anvendes hos patienter, der kan være overfølsomme (allergiske) over for paliperidon eller andre af indholdsstofferne eller over for risperidon.
Invega should not be taken by people who may be hypersensitive (allergic) to paliperidone or any of the other ingredients, or to risperidone.
Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at fordelene ved Invega i en dosis på mellem 3 og 12 mg dagligt til behandling af skizofreni opvejer risiciene.
The Committee for Medicinal Products for Human Use (CHMP) decided that, at doses of between 3 and 12 mg a day, Invega’ s benefits are greater than its risks for the treatment of schizophrenia.
Udvalget konkluderede desuden, at 6 mg én gang dagligt var en rimelig startdosis ud fra forholdet mellem fordele og risici ved de forskellige undersøgte doser.
The Committee also concluded that 6 mg once a day was a reasonable starting dose, based on the balance of benefits and risks of the different doses studied.
Udvalget anbefalede udstedelse af markedsføringstilladelse for Invega.
The Committee recommended that Invega be given marketing authorisation.
Andre oplysninger om Invega:
Other information about Invega:
Europa- Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Invega til Janssen- Cilag International NV den 25. juni 2007.
The European Commission granted a marketing authorisation valid throughout the European Union for Invega to Janssen-Cilag International NV on 25 June 2007.
Den fuldstændige EPAR for Invega findes her.
The full EPAR for Invega can be found here.
EU- nummer EU/ 1/ 07/ 395/ 001 EU/ 1/ 07/ 395/ 002 EU/ 1/ 07/ 395/ 003 EU/ 1/ 07/ 395/ 004 EU/ 1/ 07/ 395/ 005 EU/ 1/ 07/ 395/ 006 EU/ 1/ 07/ 395/ 007 EU/ 1/ 07/ 395/ 008 EU/ 1/ 07/ 395/ 009 EU/ 1/ 07/ 395/ 010 EU/ 1/ 07/ 395/ 011 EU/ 1/ 07/ 395/ 012 EU/ 1/ 07/ 395/ 013 EU/ 1/ 07/ 395/ 014 EU/ 1/ 07/ 395/ 015 EU/ 1/ 07/ 395/ 016 EU/ 1/ 07/ 395/ 017 EU/ 1/ 07/ 395/ 018 EU/ 1/ 07/ 395/ 019 EU/ 1/ 07/ 395/ 020 EU/ 1/ 07/ 395/ 021 EU/ 1/ 07/ 395/ 022 EU/ 1/ 07/ 395/ 023 EU/ 1/ 07/ 395/ 024 EU/ 1/ 07/ 395/ 025 EU/ 1/ 07/ 395/ 026 EU/ 1/ 07/ 395/ 027 EU/ 1/ 07/ 395/ 028 EU/ 1/ 07/ 395/ 029 EU/ 1/ 07/ 395/ 030 EU/ 1/ 07/ 395/ 031 EU/ 1/ 07/ 395/ 032 EU/ 1/ 07/ 395/ 033 EU/ 1/ 07/ 395/ 034 EU/ 1/ 07/ 395/ 035 EU/ 1/ 07/ 395/ 036 EU/ 1/ 07/ 395/ 037 EU/ 1/ 07/ 395/ 038
EU Number EU/ 1/ 07/ 395/ 001 EU/ 1/ 07/ 395/ 002 EU/ 1/ 07/ 395/ 003 EU/ 1/ 07/ 395/ 004 EU/ 1/ 07/ 395/ 005 EU/ 1/ 07/ 395/ 006 EU/ 1/ 07/ 395/ 007 EU/ 1/ 07/ 395/ 008 EU/ 1/ 07/ 395/ 009 EU/ 1/ 07/ 395/ 010 EU/ 1/ 07/ 395/ 011 EU/ 1/ 07/ 395/ 012 EU/ 1/ 07/ 395/ 013 EU/ 1/ 07/ 395/ 014 EU/ 1/ 07/ 395/ 015 EU/ 1/ 07/ 395/ 016 EU/ 1/ 07/ 395/ 017 EU/ 1/ 07/ 395/ 018 EU/ 1/ 07/ 395/ 019 EU/ 1/ 07/ 395/ 020 EU/ 1/ 07/ 395/ 021 EU/ 1/ 07/ 395/ 022 EU/ 1/ 07/ 395/ 023 EU/ 1/ 07/ 395/ 024 EU/ 1/ 07/ 395/ 025 EU/ 1/ 07/ 395/ 026 EU/ 1/ 07/ 395/ 027 EU/ 1/ 07/ 395/ 028 EU/ 1/ 07/ 395/ 029 EU/ 1/ 07/ 395/ 030 EU/ 1/ 07/ 395/ 031 EU/ 1/ 07/ 395/ 032 EU/ 1/ 07/ 395/ 033 EU/ 1/ 07/ 395/ 034 EU/ 1/ 07/ 395/ 035 EU/ 1/ 07/ 395/ 036
Særnavn Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
Invented name Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
Styrke 3 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg 12 mg 12 mg 3 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg
Strength 3 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg 12 mg 12 mg 3 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 9 mg 12 mg
Lægemiddelform Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet
Pharmaceutical Form Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet
Indgivelsesvej Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse
Route of Administration Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use
Emballage Blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu)
Packaging blister (PVC/ PCTFE/ alu) asdf blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu)
Paknings- størrelse 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 30 tabletter 49 tabletter
Package size 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 30 tablets 49 tablets 56 tablets 98 tablets 28 tablets
1/ 3 EU/ 1/ 07/ 395/ 039 EU/ 1/ 07/ 395/ 040 EU/ 1/ 07/ 395/ 041 EU/ 1/ 07/ 395/ 042 EU/ 1/ 07/ 395/ 043 EU/ 1/ 07/ 395/ 044 EU/ 1/ 07/ 395/ 045 EU/ 1/ 07/ 395/ 046 EU/ 1/ 07/ 395/ 047 EU/ 1/ 07/ 395/ 048 EU/ 1/ 07/ 395/ 049 EU/ 1/ 07/ 395/ 050 EU/ 1/ 07/ 395/ 051 EU/ 1/ 07/ 395/ 052 EU/ 1/ 07/ 395/ 053 EU/ 1/ 07/ 395/ 054 EU/ 1/ 07/ 395/ 055 EU/ 1/ 07/ 395/ 056 EU/ 1/ 07/ 395/ 057 EU/ 1/ 07/ 395/ 058 EU/ 1/ 07/ 395/ 059 EU/ 1/ 07/ 395/ 060 EU/ 1/ 07/ 395/ 061 EU/ 1/ 07/ 395/ 062 EU/ 1/ 07/ 395/ 063 EU/ 1/ 07/ 395/ 064 EU/ 1/ 07/ 395/ 065 EU/ 1/ 07/ 395/ 066 EU/ 1/ 07/ 395/ 067 EU/ 1/ 07/ 395/ 068 EU/ 1/ 07/ 395/ 069 EU/ 1/ 07/ 395/ 070 EU/ 1/ 07/ 395/ 071 EU/ 1/ 07/ 395/ 072 EU/ 1/ 07/ 395/ 073 EU/ 1/ 07/ 395/ 074 EU/ 1/ 07/ 395/ 075 EU/ 1/ 07/ 395/ 076 EU/ 1/ 07/ 395/ 077 EU/ 1/ 07/ 395/ 078 EU/ 1/ 07/ 395/ 079
EU/ 1/ 07/ 395/ 037 EU/ 1/ 07/ 395/ 038 EU/ 1/ 07/ 395/ 039 EU/ 1/ 07/ 395/ 040 EU/ 1/ 07/ 395/ 041 EU/ 1/ 07/ 395/ 042 EU/ 1/ 07/ 395/ 043 EU/ 1/ 07/ 395/ 044 EU/ 1/ 07/ 395/ 045 EU/ 1/ 07/ 395/ 046 EU/ 1/ 07/ 395/ 047 EU/ 1/ 07/ 395/ 048 EU/ 1/ 07/ 395/ 049 EU/ 1/ 07/ 395/ 050 EU/ 1/ 07/ 395/ 051 EU/ 1/ 07/ 395/ 052 EU/ 1/ 07/ 395/ 053 EU/ 1/ 07/ 395/ 054 EU/ 1/ 07/ 395/ 055 EU/ 1/ 07/ 395/ 056 EU/ 1/ 07/ 395/ 057 EU/ 1/ 07/ 395/ 058 EU/ 1/ 07/ 395/ 059 EU/ 1/ 07/ 395/ 060 EU/ 1/ 07/ 395/ 061 EU/ 1/ 07/ 395/ 062 EU/ 1/ 07/ 395/ 063 EU/ 1/ 07/ 395/ 064 EU/ 1/ 07/ 395/ 065 EU/ 1/ 07/ 395/ 066 EU/ 1/ 07/ 395/ 067 EU/ 1/ 07/ 395/ 068 EU/ 1/ 07/ 395/ 069 EU/ 1/ 07/ 395/ 070 EU/ 1/ 07/ 395/ 071 EU/ 1/ 07/ 395/ 072 EU/ 1/ 07/ 395/ 073
Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
12 mg 12 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg 12 mg 3 mg 3 mg 6 mg 6 mg 9 mg 9 mg 12 mg 12 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg 1. 5 mg 1. 5 mg 1. 5 mg
12 mg 12 mg 12 mg 12 mg 3 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg 9 mg 12 mg 12 mg 12 mg 12 mg 3 mg 3 mg 6 mg 6 mg 9 mg 9 mg 12 mg 12 mg 3 mg 3 mg 3 mg 6 mg 6 mg 6 mg 9 mg 9 mg 9 mg
Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet Depottablet
Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet Prolonged release tablet
Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse Oral anvendelse
Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use Oral use
blister (hvid PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) blister (OPA- Alu- PVC/ Alu) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) Flaske (HDPE/ PP) blister (PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (OPA- Alu- PVC/ Alu) blister (PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (OPA- Alu- PVC/ Alu) blister (PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (OPA- Alu- PVC/ Alu) blister (PVC/ PCTFE/ alu) blister (hvid PVC/ PCTFE/ alu) blister (OPA- Alu- PVC/ Alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu) blister (PVC/ PCTFE/ alu)
blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (OPA-alu-PVC/ alu) blister (OPA-alu-PVC/ alu) - blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) blister (OPA-Alu-PVC/ Alu) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) Bottle (HDPE/ PP) blister (PVC/ PCTFE/ alu) asdf blister (white PVC/ PCTFE/ alu) blister (OPA-alu-PVC/ alu) blister (PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (OPA-Alu-PVC/ Alu) blister (PVC/ PCTFE/ alu) blister (white PVC/ PCTFE/ alu) blister (OPA-Alu-PVC/ Alu)
56 tabletter 98 tabletter 28 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 49 tabletter 56 tabletter 98 tabletter 28 tabletter 49 tabletter 56 tabletter 98 tabletter 30 tabletter 350 tabletter 30 tabletter 350 tabletter 30 tabletter 350 tabletter 30 tabletter 350 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 14 tabletter 28 tabletter 30 tabletter
30 tablets 49 tablets 56 tablets 98 tablets 28 tablets 49 tablets 56 tablets 98 tablets 28 tablets 49 tablets 56 tablets 98 tablets 28 tablets 49 tablets 56 tablets 98 tablets 28 tablets 49 tablets 56 tablets 98 tablets 30 tablets 350 tablets 30 tablets 350 tablets 30 tablets 350 tablets 30 tablets 350 tablets 14 tablets 14 tablets 14 tablets 14 tablets 14 tablets 14 tablets 14 tablets 14 tablets 14 tablets
2/ 3 EU/ 1/ 07/ 395/ 080 EU/ 1/ 07/ 395/ 081 EU/ 1/ 07/ 395/ 082 EU/ 1/ 07/ 395/ 083 EU/ 1/ 07/ 395/ 084 EU/ 1/ 07/ 395/ 085 EU/ 1/ 07/ 395/ 086 EU/ 1/ 07/ 395/ 087 EU/ 1/ 07/ 395/ 088 EU/ 1/ 07/ 395/ 089 EU/ 1/ 07/ 395/ 090 EU/ 1/ 07/ 395/ 091 EU/ 1/ 07/ 395/ 092 EU/ 1/ 07/ 395/ 093 EU/ 1/ 07/ 395/ 094 EU/ 1/ 07/ 395/ 095
EU/ 1/ 07/ 395/ 074 EU/ 1/ 07/ 395/ 075 EU/ 1/ 07/ 395/ 076 EU/ 1/ 07/ 395/ 077 EU/ 1/ 07/ 395/ 078 EU/ 1/ 07/ 395/ 079 EU/ 1/ 07/ 395/ 080 EU/ 1/ 07/ 395/ 081 EU/ 1/ 07/ 395/ 082 EU/ 1/ 07/ 395/ 083 EU/ 1/ 07/ 395/ 084 EU/ 1/ 07/ 395/ 085 EU/ 1/ 07/ 395/ 086 EU/ 1/ 07/ 395/ 087 EU/ 1/ 07/ 395/ 088 EU/ 1/ 07/ 395/ 089 EU/ 1/ 07/ 395/ 090 EU/ 1/ 07/ 395/ 091 EU/ 1/ 07/ 395/ 092 EU/ 1/ 07/ 395/ 093 EU/ 1/ 07/ 395/ 094 EU/ 1/ 07/ 395/ 095
Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega Invega
1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg 1. 5 mg
12 mg 12 mg 12 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg 1.5 mg